Streetz, Konrad L.

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature

RNA Interference and Gene DeliveryMicroRNA in disease regulation

Cited by 1,677

Interleukin 6 and liver regeneration

STREETZ, K. L., LUEDDE, T., MANNS, M. P., & TRAUTWEIN, C. (2000) · Gut

Liver physiology and pathologyCytokine Signaling Pathways and Interactions

Cited by 238

Concanavalin A—induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice☆☆☆

Trautwein, C., Rakemann, T., Brenner, D. A., Streetz, K., Licato, L., Manns, M. P., & Tiegs, G. (1998) · Gastroenterology

Cell death mechanisms and regulationLiver physiology and pathology

Cited by 147

Lack of gp130 expression in hepatocytes promotes liver injury1 1K.L.S. and T.W. contributed equally to this work.

StreetZ, K. L., Wüstefeld, T., Klein, C., Kallen, K.-J., Tronche, F., Betz, U. A. K., Schütz, G., Manns, M. P., Müller, W., & Trautwein, C. (2003) · Gastroenterology

Cytokine Signaling Pathways and InteractionsLiver physiology and pathology

Cited by 94

Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice

Kroy, D. C., Beraza, N., Tschaharganeh, D. F., Sander, L. E., Erschfeld, S., Giebeler, A., Liedtke, C., Wasmuth, H. E., Trautwein, C., & Streetz, K. L. (2010) · Hepatology

Cytokine Signaling Pathways and InteractionsLiver Disease Diagnosis and Treatment

Cited by 76

Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man

Luchtefeld, M., Schunkert, H., Stoll, M., Selle, T., Lorier, R., Grote, K., Sagebiel, C., Jagavelu, K., Tietge, U. J. F., Assmus, U., et al. (2007) · The Journal of Experimental Medicine

Atherosclerosis and Cardiovascular DiseasesCytokine Signaling Pathways and Interactions

Cited by 69

Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development

Ramadori, P., Drescher, H., Erschfeld, S., Schumacher, F., Berger, C., Fragoulis, A., Schenkel, J., Kensler, T. W., Wruck, C. J., Trautwein, C., et al. (2016) · Free Radical Biology and Medicine

Liver Disease Diagnosis and TreatmentGenomics, phytochemicals, and oxidative stress

Cited by 61

ME3738 protects from concanavalin A‐induced liver failure via an IL‐6‐dependent mechanism

Klein, C., Wüstefeld, T., Heinrich, P. C., Streetz, K. L., Manns, M. P., & Trautwein, C. (2003) · European Journal of Immunology

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 27